Paragon Associates & Paragon Associates II Joint Venture’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,500
Closed -$2.73M 19
2021
Q2
$2.73M Sell
11,500
-8,500
-43% -$2.12M 3.63% 12
2021
Q1
$4.83M Buy
+20,000
New +$4.46M 7.37% 7
2020
Q3
Sell
-10,000
Closed -$1.88M 10
2020
Q2
$1.88M Buy
+10,000
New +$1.9M 2.06% 8
2020
Q1
Sell
-50,000
Closed -$10.2M 16
2019
Q4
$10.2M Sell
50,000
-5,000
-9% -$917K 5.75% 7
2019
Q3
$8.35M Buy
55,000
+20,000
+57% +$3.25M 6.44% 8
2019
Q2
$5.51M Buy
+35,000
New +$5.48M 4.25% 9

Other funds holding CI

Paragon Associates & Paragon Associates II Joint Venture's CI Position: Q3 2021 in Review

Paragon Associates & Paragon Associates II Joint Venture sold out of Cigna (CI) in Q3 2021, closing a stake of 11,500 shares — an estimated $2.73M sold.

Paragon Associates & Paragon Associates II Joint Venture first reported a position in CI in Q2 2019 and held it in 6 quarters. The position peaked at $10.2M in Q4 2019. 1,247 funds tracked by Wall St. Rank hold CI as of Q3 2021.

  • Paragon Associates & Paragon Associates II Joint Venture reported no remaining Cigna position as of Q3 2021 after selling out during the quarter.
  • Paragon Associates & Paragon Associates II Joint Venture sold 11,500 Cigna shares in Q3 2021, an estimated $2.73M.
  • Paragon Associates & Paragon Associates II Joint Venture first reported a position in Cigna in Q2 2019 and held it in 6 quarters.
  • Paragon Associates & Paragon Associates II Joint Venture's Cigna position peaked at $10.2M in Q4 2019.
  • 1,247 funds tracked by Wall St. Rank held Cigna as of Q3 2021.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q3 2021, filed 15 Nov 2021.